UnitedHealth Group's Earnings Rebound Sparks Valuation Debate

UnitedHealth Group (UNH) has raised its full-year earnings outlook and outlined improving medical cost trends, which has put investors in a dilemma. The company's recent guidance raise and new partnership with Optum Health in Florida are positives, but the share price has pulled back over the past few weeks.

The stock is currently down 4.5% over the past week and 6.4% over the past 90 days, but it still shows a strong year-to-date return of 11.6%. The company's one-year total shareholder return is at 12.8%, suggesting that near-term optimism is rebuilding after a tougher multi-year stretch.

UnitedHealth Group is considered undervalued by some investors, with a fair value framework of $475.23, but the share price has pulled back to $375.26. The company's narrative could be shaken if Medicare utilization stays higher than expected or if execution on the new CMS risk model falls short.